ArticleInfectious diseases and therapy2024

Real-World Effectiveness of Ensitrelvir in Reducing Severe Outcomes in Outpatients at High Risk for COVID-19.

Takahiro Takazono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.